We are happy to announce that we have been able to add a wide range of advanced drugs that are specially designed to treat various forms of cancers. These chemotherapies can now be purchased from IsraelPharm at far lower prices than the standard cost in US pharmacies – at an average discount of nearly 85%.
In every case, the drug we supply is sourced from the original company that holds exclusive rights (see more in FAQ) and comes to you in the original format and with guarantees of complete end-to-end quality controls.
IsraelPharm can offer you these remarkable discounts because pharmaceutical prices in Israel are capped and subsidized by the state’s socialized medical system – one of the most user-friendly and technically advanced in the free world. Thanks to our unique position straddling the two countries we can offer our customers in the US the same drugs that they could be buying at home, but often at barely one tenth of the price.
In the table below, we are listing the drugs that we have added in the past few months to our range of chemotherapy treatments for a wide variety of cancers. Please visit our website to read more about these exciting additions, and to place your order for quick delivery.
| Drug | Main action | US retail cost
Per tablet |
IsraelPharm price
Per tablet |
| Afinitor
(everolimus) |
prescribed for a wide range of cancers, tumors and carcinomas, | 10mg – $580
5mg – $580 2.5mg – $560 |
10mg – $110
5mg – $61 2.5mg – $28 |
| Sutent
(sunitinib) |
treats gastrointestinal stromal tumors and advanced renal cell carcinoma (RCC | 50mg – $225 | 50mg – $92 |
| Tarceva
(erlotinib) |
treatment for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) | 150mg – $88 | 150mg – $29 |
| Xalkori
(crizotinib) |
prescribed to treat people with non-small cell lung cancer (NSCLC) | 200mg – $344
250mg – $344 |
200mg – $47
250mg – $50 |
| Zelboraf
(vemurafenib) |
for treatment of patients carrying BRAF V600E genetic mutation with metastatic melanoma or Erdheim–Chester blood disease (ECD) | 240mg – $50 | 240mg – $11.50 |
| Zytiga
(abiraterone acetate) |
for metastatic high-risk castration-sensitive prostate cancer (CSPC) in men | 250mg – $96 | 250mg – $14 |
| Tafinlar
(dabrafenib) |
treats metastatic and inoperable melanomas, non-small cell lung cancer (NSCLC) and anaplastic thyroid cancer (ATC) | 75mg – $108 | 75mg – $14 |
FAQ
For how long do drug companies have exclusive rights?
Apart from patent rights, companies can have exclusive rights for manufacture and distribution of new drugs. Patent is valid for 20 years from the date on which the application was filed in the United States. Drug exclusivity lasts for five years during which the company has exclusive rights to manufacture and distribute the new drug.
How long is Orphan Drug exclusivity?
The FDA can issue approval for orphan drugs which show promise in the treatment, prevention, or diagnosis of rare diseases or conditions that affect fewer than 200,000 people in the United States. Example: Zelboraf (vemurafenib) was designated as an orphan drug in 2014, and the designation expired in 2021, which means it is now an exclusive product for the originator, Roche.
